Increased use of Artificial Intelligence (AI) in healthcare will warrant greater legal governance.

The focus on growing the Life Sciences sector in the Labour manifesto present both risks and opportunities for insurers. Our experts outline what those opportunities look like and also how risks should be analysed and managed.

The opportunities for equipment manufacturers and software developers appear to be almost limitless. From tele-radiology and dermatology to using AI in diagnosis – all present unique challenges, but have similar medico-legal issues at their core.

At our webinar on 29 September, we reviewed Product Claims in a healthcare setting, which can arise in multiple types of claims.

This article considers the importance of ensuring that a participant in a clinical trial has given informed consent from a claims perspective.

The last year has seen a rapid acceleration in the use of remote electronic consultations. Clear benefits to clinicians and patients coupled with pressure on resources mean that we are unlikely to go back to the way things were before.

In recent years we have started to see Artificial Intelligence (AI) being used across medicine from radiology reporting to cancer diagnosis and ophthalmology.

With increasing demands on GPs, the rise of telemedicine is set to continue. Providers will need to ensure that they comply with legislation around supply of medicines across the internet.

The end of MedTech week coincides with the start of a new football season. In a week when the father of a schoolboy footballer who sadly collapsed during a football match and died three days later from an underlying undiagnosed cardiac condition